Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pliant Therapeutics (PLRX) Gains from Investment Securities (2019 - 2026)

Pliant Therapeutics has reported Gains from Investment Securities over the past 7 years, most recently at -$323000.0 for Q1 2026.

  • Quarterly Gains from Investment Securities fell 3937.5% to -$323000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$315000.0 through Mar 2026, up 98.67% year-over-year, with the annual reading at $43000.0 for FY2024, N/A changed from the prior year.
  • Gains from Investment Securities was -$323000.0 for Q1 2026 at Pliant Therapeutics, down from $8000.0 in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $23.7 million in Q1 2024 and troughed at -$29.7 million in Q4 2024.
  • The 4-year median for Gains from Investment Securities is $0.0 (2025), against an average of -$46000.0.
  • Year-over-year, Gains from Investment Securities tumbled 99.87% in 2025 and then crashed 3937.5% in 2026.
  • A 4-year view of Gains from Investment Securities shows it stood at -$1.2 million in 2022, then crashed by 2483.49% to -$29.7 million in 2024, then skyrocketed by 100.03% to $8000.0 in 2025, then plummeted by 4137.5% to -$323000.0 in 2026.
  • Per Business Quant, the three most recent readings for PLRX's Gains from Investment Securities are -$323000.0 (Q1 2026), $8000.0 (Q2 2025), and -$8000.0 (Q1 2025).